Carcinoma of the mammary gland in a mare | Zendy

Bussche L. | Zendy; Harms C. | Zendy; Buckles E. L. | Zendy; Whelchel D. | Zendy; Brosnahan M. | Zendy; Van de Walle G. R. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Carcinoma of the mammary gland in a mare

Author(s) -

Bussche L.,

Harms C.,

Buckles E. L.,

Whelchel D.,

Brosnahan M.,

Van de Walle G. R.

Publication year - 2017

Publication title -

equine veterinary education

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.304

H-Index - 31

eISSN - 2042-3292

pISSN - 0957-7734

DOI - 10.1111/eve.12500

Subject(s) - mammary gland , vimentin , cytokeratin , medicine , pathology , immunohistochemistry , histopathology , parenchyma , downregulation and upregulation , cancer , horse , carcinoma , breast cancer , biology , gene , paleontology , biochemistry

Summary A 20‐year‐old Quarter Horse mare was presented with a firm, nonpainful swelling near the axial margin of the left mammary gland. Ultrasound examination of the mass revealed a 35 mm poorly encapsulated, homogeneous mass within the parenchyma of the left mammary gland. Using histopathology and immunohistochemistry, the mass was diagnosed as a mammary carcinoma and showed positivity for cytokeratin 18 ( CK 18), vimentin and α‐smooth muscle actin. Additionally, the mRNA expression level of the oncogene cM yc did not show a significant upregulation, whereas p53 , a well‐known tumour suppressor gene in breast cancer, was significantly reduced in comparison with healthy equine mammary gland tissue. To the authors' knowledge, this is the first report of a significant downregulation of p53 expression in a mammary carcinoma of a mare.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research